Learn More
Medchemexpress LLC Ulipristal acetate | 126784-99-4 | 475.62 | 100 MG

Supplier: Medchemexpress LLC HY16508100MG
Ulipristal acetate (CDB-2914) is an orally active, selective progesterone receptor modulator (SPRM). It stimulates the autophagic response selectively in leiomyoma cells and has potential for treating benign gynecological conditions like uterine myoma.
- Orally active, selective progesterone receptor modulator
- Stimulates autophagy in leiomyoma cells
- Potential for treating benign gynecological conditions, such as uterine myoma
- Blocks activin A modulation of fibronectin and vascular endothelial growth factor A (VEGF-A) mRNA expression
- Possesses significant antiprogestational activity in vivo
- Decreases incidences of fibroadenomas and adenocarcinomas in the mammary gland
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.